Erdheim–Chester disease: a systematic review

M Cives, V Simone, FM Rizzo, F Dicuonzo… - Critical reviews in …, 2015 - Elsevier
Erdheim–Chester disease (ECD) is a rare form of non-Langerhans-cell histiocytosis,
associated in more than 50% of cases to BRAF V600E mutations in early multipotent …

MEK1/2 inhibitors in the treatment of gynecologic malignancies

CR Miller, KE Oliver, JH Farley - Gynecologic oncology, 2014 - Elsevier
Mitogen-activated protein kinases (MAPKs) are a family of ubiquitous eukaryotic signal
transduction enzymes which link extracellular stimuli to intracellular gene expression …

[HTML][HTML] MALAT1/miR-15b-5p/MAPK1 mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling …

Y Zhu, T Yang, J Duan, N Mu, T Zhang - Aging (Albany NY), 2019 - ncbi.nlm.nih.gov
Objective: Present study focused on the influence of lncRNA MALAT1 on coronary
atherosclerotic heart disease (CAD) by regulating miR-15b-5p/MAPK1 and mTOR signaling …

Actionable gene-based classification toward precision medicine in gastric cancer

H Ichikawa, M Nagahashi, Y Shimada, T Hanyu… - Genome Medicine, 2017 - Springer
Background Intertumoral heterogeneity represents a significant hurdle to identifying
optimized targeted therapies in gastric cancer (GC). To realize precision medicine for GC …

MEK1 is associated with carboplatin resistance and is a prognostic biomarker in epithelial ovarian cancer

Z Pénzváltó, A Lánczky, J Lénárt, N Meggyesházi… - BMC cancer, 2014 - Springer
Background Primary systemic treatment for ovarian cancer is surgery, followed by platinum
based chemotherapy. Platinum resistant cancers progress/recur in approximately 25% of …

Genome-wide quantification of copy-number aberration impact on gene expression in ovarian high-grade serous carcinoma

S Jamalzadeh, J Dai, K Lavikka, Y Li, J Jiang… - BMC cancer, 2024 - Springer
Copy-number alterations (CNAs) are a hallmark of cancer and can regulate cancer cell
states via altered gene expression values. Herein, we have developed a copy-number …

Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry

XK Lun, VRT Zanotelli, JD Wade, D Schapiro… - Nature …, 2017 - nature.com
Signaling networks are key regulators of cellular function. Although the concentrations of
signaling proteins are perturbed in disease states, such as cancer, and are modulated by …

[PDF][PDF] RETRACTED ARTICLE: MicroRNA-675 directly targets MAPK1 to suppress the oncogenicity of papillary thyroid cancer and is sponged by long non-coding …

J Wang, T Xiao, M Zhao - OncoTargets and therapy, 2019 - Taylor & Francis
Wang J, Xiao T, Zhao M. Onco Targets Ther. 2019; 12: 7307–7321. The Editor and Publisher
of OncoTargets and Therapy wish to retract the published article. Concerns were raised over …

MicroRNAs as biomarkers for early diagnosis, prognosis, and therapeutic targeting of ovarian cancer

Y Mirahmadi, R Nabavi, F Taheri… - Journal of …, 2021 - Wiley Online Library
Ovarian cancer is the major cause of gynecologic cancer‐related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …

MicroRNA‐508 suppresses epithelial‐mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway

L Hong, Y Wang, W Chen… - Journal of cellular …, 2018 - Wiley Online Library
Ovarian cancer (OC) is the sixth most common cancer in women worldwide. Despite
advances in detection and therapies, it still represents the most lethal gynecologic …